Eystein S Husebye Selected Research

Autoimmune Polyendocrinopathies (Schmidt Syndrome)

9/2021	B Cells and Autoantibodies in AIRE Deficiency.
1/2017	Autoantibody Repertoire in APECED Patients Targets Two Distinct Subgroups of Proteins.
2/2016	Proteome-wide survey of the autoimmune target repertoire in autoimmune polyendocrine syndrome type 1.
10/2013	BPIFB1 is a lung-specific autoantigen associated with interstitial lung disease.
2/2010	Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokines.
3/2009	Autoantibodies in autoimmune polyglandular syndrome type I patients react with major brain neurotransmitter systems.
10/2008	Interferon autoantibodies associated with AIRE deficiency decrease the expression of IFN-stimulated genes.
3/2008	Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen.
6/2002	AIRE mutations and human leukocyte antigen genotypes as determinants of the autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy phenotype.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Eystein S Husebye Research Topics

Disease

33	Addison Disease (Addison's Disease) 03/2021 - 02/2002
11	type 1 Autoimmune polyendocrinopathy syndrome 06/2017 - 04/2003
9	Adrenal Insufficiency (Adrenal Gland Hypofunction) 11/2021 - 03/2007
9	Autoimmune Polyendocrinopathies (Schmidt Syndrome) 09/2021 - 06/2002
9	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 04/2004
6	Congenital Adrenal Hyperplasia (Hyperplasia, Congenital Adrenal) 08/2022 - 09/2010
6	Hypoparathyroidism 01/2016 - 02/2004
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2016 - 02/2002
4	Thymoma (Thymic Carcinoma) 10/2014 - 11/2008
3	Congenital adrenal hyperplasia due to 21 hydroxylase deficiency 08/2022 - 01/2018
3	Neoplasms (Cancer) 01/2022 - 10/2014
3	Cushing Syndrome 05/2021 - 03/2007
3	Fatigue 01/2016 - 05/2002
3	Chronic Mucocutaneous Candidiasis 10/2014 - 11/2008
2	Pneumonia (Pneumonitis) 01/2021 - 10/2020
2	COVID-19 01/2021 - 10/2020
2	Thyroid Diseases (Thyroid Disease) 12/2016 - 02/2016
2	Myasthenia Gravis 04/2012 - 11/2008
2	Hypogonadism (Hypergonadotropic Hypogonadism) 10/2009 - 02/2004
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 08/2022
1	Lipodystrophy 01/2022
1	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2022
1	Spontaneous Abortion (Miscarriage) 01/2022
1	Panniculitis 01/2022
1	Ectopic Pregnancy 01/2022
1	Obesity 05/2021
1	Vomiting 01/2021
1	Adrenocorticotropic hormone deficiency 01/2021
1	Hyperpigmentation 01/2021
1	Adrenal incidentaloma 10/2020
1	Hyperplasia 10/2020
1	Hyperglycemia 06/2019
1	Hyperandrogenism 01/2019
1	Fibrosis (Cirrhosis) 03/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Hypertension (High Blood Pressure) 01/2018
1	Diabetes Mellitus 01/2018
1	Overweight 01/2018
1	Vitiligo 12/2016
1	Pernicious Anemia 12/2016
1	Chronic Kidney Failure (Chronic Renal Failure) 10/2016
1	Interstitial Nephritis (Tubulointerstitial Nephritis) 10/2016
1	Infections 03/2016
1	Dental Enamel Hypoplasia 01/2016

Drug/Important Bio-Agent (IBA)

35	AutoantibodiesIBA 01/2022 - 02/2002
10	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2021 - 06/2003
10	GlucocorticoidsIBA 03/2021 - 01/2005
10	Steroid 21-Hydroxylase (21 Hydroxylase)IBA 03/2020 - 01/2004
10	AutoantigensIBA 06/2017 - 02/2004
9	AntibodiesIBA 03/2020 - 02/2002
8	EnzymesIBA 08/2022 - 04/2003
8	InterferonsIBA 10/2020 - 10/2008
7	Hormones (Hormone)IBA 08/2022 - 04/2003
6	SteroidsIBA 08/2022 - 08/2009
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 02/2004
4	AntigensIBA 01/2016 - 04/2003
3	Glucose (Dextrose)FDA LinkGeneric 06/2019 - 07/2015
3	Dehydroepiandrosterone (DHEA)IBA 01/2019 - 03/2003
3	Interleukin-22 (IL-22)IBA 01/2018 - 02/2010
3	CytokinesIBA 01/2018 - 02/2010
3	Neurotransmitter Agents (Neurotransmitter)IBA 02/2014 - 04/2003
3	HLA Antigens (Human Leukocyte Antigens)IBA 12/2009 - 02/2002
3	HLA-DRB1 Chains (HLA DRB1)IBA 12/2009 - 02/2002
3	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 03/2009 - 02/2002
2	Cosyntropin (Cortrosyn)FDA LinkGeneric 08/2022 - 01/2018
2	Cortisone FDA Link 05/2021 - 05/2002
2	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2021 - 10/2020
2	SaltsIBA 01/2021 - 01/2019
2	Immunoglobulin G (IgG)IBA 10/2020 - 01/2004
2	Adrenal Cortex Hormones (Corticosteroids)IBA 02/2016 - 09/2010
2	Interleukin-2 (IL2)IBA 03/2015 - 09/2008
2	Interleukin-17 (Interleukin 17)IBA 10/2014 - 02/2010
2	Interferon Type IIBA 07/2014 - 04/2012
2	Amino Acids FDA Link 12/2009 - 04/2004
2	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 12/2009 - 08/2009
2	Aromatic-L-Amino-Acid DecarboxylasesIBA 03/2009 - 04/2003
2	FludrocortisoneIBA 04/2008 - 05/2002
2	MineralocorticoidsIBA 04/2008 - 01/2005
2	Pyridoxal Phosphate (Pyridoxal 5 Phosphate)IBA 04/2004 - 04/2003
1	17-alpha-Hydroxyprogesterone (17 Hydroxyprogesterone)IBA 08/2022
1	Perilipin-1IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 03/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Toll-Like Receptor 3IBA 04/2019
1	PregnenoloneIBA 01/2019
1	Dehydroepiandrosterone SulfateIBA 01/2019
1	Genetic Markers (Genetic Marker)IBA 01/2018
1	Vitamin D FDA LinkGeneric 01/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2017
1	Endothelins (Endothelin)IBA 06/2017
1	PhosphoproteinsIBA 01/2017
1	SandIBA 12/2016
1	Aquaporins (Water Channels)IBA 10/2016
1	ProteomeIBA 02/2016

Therapy/Procedure

14	Therapeutics 01/2021 - 05/2002
1	Induced Abortion (Induced Abortions) 01/2022
1	Immunotherapy 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Aftercare (After-Treatment) 03/2018
1	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2018